The EPS projection of CEPHEID (NASDAQ:CPHD) for quarter ended 2016-09-30 is $-0.12. A week before, the EPS forecast was $-0.12 against target of $-0.12, a month earlier. This estimate stood at $-0.12 60 days earlier versus forecast of $-0.12 90 days earlier, confirming a deviation of 0%.
CEPHEID (NASDAQ:CPHD) reported that 18 days ago, the positive EPS revisions were 1 and negative revisions at 1.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 1, 1, 0 and 1, respectively.
The downgrade of EPS estimates for CEPHEID (NASDAQ:CPHD) in the preceding 120, 60, 30 and 90 days were 1, 1, 0 and 1, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of CEPHEID (NASDAQ:CPHD) was $-0.12. This projection was computed after accounting 6 calls. As reported on 2016-04-28 the EPS was $-0.04. The change was $0.13, demonstrating a percentage deviation of 76.47%. The projections confirmed a standard deviation of 0.05.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for CEPHEID (NASDAQ:CPHD) stands at $202.102 and the median estimate at $201.2. Almost 3 analysts announced their estimates.
The highest estimate is $204.69 while the lowest target is $200.418 showing standard deviation of 2.274%.
As many as 3 analysts released sales estimates reised in upside while 3 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 3 revised sales number projection on upside while 3 lowered the sales target, demonstrating a deviation of -0.223%.
A quarter ago, 3 hiked sales estimations and 3 reduced sales forecast. CEPHEID (NASDAQ:CPHD) stated that the change in forecast was -0.752%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...